Brief: Cadrenal Therapeutics Inc - Prospectus Filed For Resale Of Up To 1.2 Million Shares Of Common Stock By Selling Stockholders- SEC Filing
21/04/2026 11:16
April 21 (Reuters) - Cadrenal Therapeutics Inc CVKD.O: CADRENAL THERAPEUTICS INC - PROSPECTUS FILED FOR RESALE OF UP TO 1.2 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS- SEC FILING Source text: [ID:n0001213900-26-045776] Further company coverage: CVKD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cadrenal Therapeutics
See all newsCadrenal Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Cadrenal Therapeutics Q2 net loss narrows as operating expenses fall
Cadrenal Therapeutics Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Marvell Technology